Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2010 - 2020)
Harvard Bioscience (HBIO) reported Asset Writedowns and Impairment of $787000.0 for Q4 2020, up 156.17% year-over-year from $307212.9 in Q1 2020, and up 19575.0% quarter-over-quarter from $4000.0 in Q1 2020.
Harvard Bioscience (HBIO) Asset Writedowns and Impairment (2010 - 2020) Analysis & Trends
Harvard Bioscience (HBIO) has 11 years of Asset Writedowns and Impairment data on file, last reported at $787000.0 in Q4 2020.
- Asset Writedowns and Impairment for Q4 2020 came in at $787000.0, up 156.17% year-over-year; the trailing twelve-month figure through Dec 2020 was $791000.0 (up 127.3% YoY), and the FY2020 annual result was $787000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment grew to $787000.0 in Q4 2020 per HBIO's latest filing, from $4000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $941000.0 in Q2 2019 and troughed at -$1.4 million in Q4 2019.
- A 5-year average of $136133.3 and a median of $31000.0 in 2017 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 6860.0% in 2019 and fell as far as 6468.18% in 2019.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $250000.0 in 2016, then slumped by 144.0% to -$110000.0 in 2017, then soared by 120.0% to $22000.0 in 2018, then slumped by 6468.18% to -$1.4 million in 2019, then surged by 156.17% to $787000.0 in 2020.
- Business Quant data shows HBIO's Asset Writedowns and Impairment at $787000.0 in Q4 2020, $4000.0 in Q1 2020, and -$1.4 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 787,000.00 |
| Dec 31, 2020 | 787,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | -1.40 Mn |
| Dec 31, 2019 | -1.40 Mn |
| Sep 30, 2019 | 460,000.00 |
| Sep 30, 2019 | 460,000.00 |
| Jun 30, 2019 | 941,000.00 |
| Jun 30, 2019 | 941,000.00 |
| Mar 31, 2019 | 348,000.00 |
| Mar 31, 2019 | 348,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |
| Dec 31, 2017 | -110,000.00 |
| Dec 31, 2017 | -110,000.00 |
| Jun 30, 2017 | 31,000.00 |
| Jun 30, 2017 | 31,000.00 |